Netupitant/palonosetron (NEPA; Akynzeo®) combination in prevention of the nausea and vomiting in patients with breast cancer receiving anthracyclinbased chemotherapy
Chemotherapy-induced nausea and vomiting is a common problem during cancer treatment, especially in breast cancer patients with anthracycline/cyclophosphamide (ас) chemotherapy. Netupitant/palonosetron (NEPA; Akynzeo®) is a fixed-dose combination of two drugs (netupitant, a neurokinin 1 receptor ant...
Saved in:
Main Authors: | A. G. Kedrova, A. I. Berishvili |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2023-10-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/1138 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nausea and vomiting induced by pharmacotherapy: have all issues of maintenance therapy been resolved?
by: M. M. Konstantinova, et al.
Published: (2023-06-01) -
Netupitant / palonosetron with dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous hematopoietic stem cell transplantation: a single-center experience
by: N. E Mochkin, et al.
Published: (2025-03-01) -
Experimental study to assess the effectiveness of moxibustion on nausea and vomiting in pregnancy
by: Henni Fitria, et al.
Published: (2025-06-01) -
THE PROBLEM OF POST-OPERATIVE NAUSEA AND VOMITING IN THE PATIENTS UNDERGOING NEUROSURGERY
by: M. I. Klyukin, et al.
Published: (2018-01-01) -
Palonosetron versus tropisetron with dexamethasone for prevention of postoperative nausea and vomiting in pediatric adenotonsillectomy: a single center, randomized controlled trial
by: Hualin Chen, et al.
Published: (2025-08-01)